[17] Procedures like sleeve gastrectomy and Roux-en-Y gastric bypass alter gut hormone profiles in ways that partially overlap with GLP-1 medications
This includes what you use, how often you use it, when you use it, why you use it, and what symptoms you already have
CrossRef Intestinal congestion-driven gut dysbiosis: a cross-disease hemodynamic mechanism in liver cirrhosis and heart failure Yan Wang, Zhongyuan Bai, Jing Sun, Qi Gong, Wentao Miao, Zhiqiang Niu, Xiang Li, Jun Xu, Zhiyong Lai Journal of Translational Medicine .2025;[Epub] CrossRef Research Progress on the Relationship between Gut Microbiota and Metabolites and Hepatitis B-Related Liver Disease Advances in Clinical Medicine .2024
Creating a sequence of target trials We emulated a sequence of 135 target trials between January 2013 and March 2024
In animal experiments, the GLP-1RA liraglutide was found to stimulate the secretion of ANP by increasing the levels of Epac2, which is a downstream target of GLP-1R signaling in cardiomyocytes (132), However, this finding seemed to contradict the results of clinical studies in which no increase was observed in the levels of ANP in healthy people and patients with T2MD
Scopolamine patch: For severe refractory nausea